NTRK2 and medulloblastoma: NTRK2 has been implicated in several types of cancers, including neuroblastoma, medulloblastoma, Wilm’s tumor, and adenocarcinomas of the lung, prostate, and pancreas as well as multiple myeloma (Yuzugullu et al., 2016).